For people with celiac disease, there’s one way to avoid symptoms: don’t eat gluten. But what if a vaccine and some booster shots could let you eat all the wheat-filled food you want, without all the nasty consequences? That’s the kind... Read more »
If you’re like me, you spend your days toggling back and forth between a dozen or so tabs crowding the top of your computer screen: One for e-mail, a few for social media, a few for news, one to monitor college... Read more »
As the news emerged of Richmond, CA-based Sangamo Biosciences’s progress toward a gene therapy treatment for HIV infection, the media buzzed and investors boosted the company’s share price by 17 percent Thursday.
For the first time, Sangamo (NASDAQ: SGMO) had... Read more »
Seattle-area startups Illumagear, maker of safety lighting for construction workers, and ComputeNext, a cloud-services marketplace, attracted funding recently. Meanwhile, Paul Allen and the Bonneville Power Administration plan to bankroll researchers focused on artificial intelligence and the regional power system, respectively. And... Read more »
Marc Andreessen spoke at Stanford’s Graduate School of Business on Tuesday, March 4, to a packed audience that included his wife, Laura Arillaga-Andreessen, and his father-in-law, John Arillaga.
Andreessen covered topics from his views on the current tech landscape to how... Read more »
Cerulean Pharma whiffed on its first attempt to prove that a nanoparticle-based cancer drug its been developing could help terminally ill lung cancer patients live longer. Now the Cambridge, MA-based company is going public to get the financial backing to see... Read more »
[Updated 3/10/14, 12:48 pm, after speaking with Drifty officials.]
Drifty, the Madison, WI-based startup that builds online platforms for people to create websites and mobile applications, has raised $1 million in a private securities offering, according to a document... Read more »
Scientists have tried for years to make an effective HIV vaccine, only to be thwarted by the shifty, mutating virus’s ability to evade the immune system. But vaccine development efforts continue, as evidenced by a bi-coastal collaboration Seattle BioMed has just... Read more »
Thirty miles north of Boston, and a million miles from Silicon Valley, they have a different way of doing innovation.
The city is Lawrence, MA. It’s an old mill town with the distinction of being one of the poorest cities in... Read more »